Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. (Q44352147)

2 December 2017

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. (English)

1 reference

2 December 2017

M Sundqvist

1

1 reference

2 December 2017

P Geli

2

1 reference

2 December 2017

D I Andersson

3

1 reference

2 December 2017

M Sjölund-Karlsson

4

1 reference

2 December 2017

A Runehagen

5

1 reference

2 December 2017

H Cars

6

1 reference

2 December 2017

K Abelson-Storby

7

1 reference

2 December 2017

O Cars

8

1 reference

2 December 2017

G Kahlmeter

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

8 November 2009

1 reference

Journal of Antimicrobial Chemotherapy

2 December 2017

1 reference

2 December 2017

65

1 reference

2 December 2017

2

1 reference

2 December 2017

350-360

1 reference

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

2 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Variation in antibiotic use in the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

The biological cost of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Fitness cost of chromosomal drug resistance-conferring mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

The population genetics of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Resistance to trimethoprim and sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Epidemiological differences among pneumococcal serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Clonal spread of resistant pneumococci despite diminished antimicrobial use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

The biological cost of mutational antibiotic resistance: any practical conclusions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

The rise and fall of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Antibiotic resistance in the absence of selective pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Enhancement of bacterial competitive fitness by apramycin resistance plasmids from non-pathogenic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP387

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP387

1 reference

2 December 2017

1 reference